The product of the eleven–nineteen lysine-rich leukaemia (ELL) gene was first identified as a translocation partner of the mixed-lineage leukaemia (MLL) gene in acute myeloid leukaemia (AML)1. The gene discussed is KMT2A; the disease is acute myeloid leukemia.